| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks | CFO &Cbo | EVP, CFO And Treasurer
3 companies
Shah Preetam serves as a CFO &Cbo at CDTX and has filed Form 4s across 3 companies. Across recent SEC filings that breaks down to 2 buys and 3 sells. Those positions are worth an estimated $54K at current prices.
Historically, Shah Preetam's trades have earned a below-average insider score of 35/100 across 4 rated trades. Over a 12-month horizon, 25.0% of those trades were profitable, with an average 12-month return of -25.6%.
The biggest single holding is BCLI (~$54K) as EVP, CFO And Treasurer. Net of sales, the recent Form 4 record there shows accumulation of 11,600 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 11, 2024 | CFO &Cbo | Sell | 18,931 | $0.67 | $12,679.98 | -7.7% | +1.6% | +58.9% | ||
| Mar 13, 2023 | CFO &Cbo | Sell | 6,648 | $1.53 | $10,171.44 | -4.3% | -28.9% | -60.5% | ||
| Sep 19, 2022 | CFO &Cbo | Sale+OE | 15,642 | $0.77 | $12,034.95 | -9.4% | -36.6% | +38.2% | ||
| Nov 12, 2021 | CFO &Cbo | Buy | 20,000 | $1.54 | $30,800.00 | New | -48.3% | -65.8% | ||
| Dec 24, 2019 | BCLI Brainstorm Cell Therapeutics Inc. | EVP, CFO And Treasurer | Buy | 11,600 | $3.96 | $45,929.04 | +46.4% | - | - |